Advaxis, Inc. | Business Contracts

Subscription and Investment Representation Agreement, dated December 1, 2022, by and between Advaxis, Inc. and the purchaser signatory thereto (Filed With SEC on December 2, 2022)

Voting and Support Agreement, by and between the Company and aMoon Growth Fund Limited Partnership, dated as of October 18, 2022 (Filed With SEC on October 19, 2022)

Agreement and Plan of Merger and Reorganization, by and among the Company, Merger Sub, and Ayala, dated as of October 18, 2022 (Filed With SEC on October 19, 2022)

Amendment No. 1 to the employment agreement between Advaxis, Inc. and Kenneth A. Berlin, dated September 12, 2022 (Filed With SEC on September 13, 2022)

Description of each class of securities registered under Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on February 14, 2022)

Lease Termination and Surrender Agreement, dated March 26, 2021, by and between the Company and 300 CR LLC (Filed With SEC on March 30, 2021)

Voting and Support Agreement, by and between the Company and Israel Biotech Fund I, L.P., dated as of October 18, 2022 (Filed With SEC on October 19, 2022)

Form of Warrant (Filed With SEC on June 13, 2022)

Form of Warrant (Filed With SEC on May 24, 2022)

Form of Underwriting Agreement (Filed With SEC on May 24, 2022)

Form of Securities Purchase Agreement between Advaxis, Inc. and the investors thereto, dated January 27, 2022 (Filed With SEC on January 28, 2022)

Form of Registration Rights Agreement by and among Advaxis, Inc. and the investors named therein (Filed With SEC on January 28, 2022)

Termination Letter from Advaxis, Inc. to Biosight LTD., dated December 30, 2021 (Filed With SEC on December 30, 2021)

Form of Registration Rights Agreement (Filed With SEC on November 9, 2021)

Form of Securities Purchase Agreement (Filed With SEC on November 9, 2021)

Form of Support Agreement, dated as of July 4, 2021, by and between the Company, Biosight and each director and executive officer of the Company or Biosight (Filed With SEC on July 6, 2021)

Agreement and Plan of Merger and Reorganization, by and among the Company, Merger Sub, and Biosight, dated as of July 4, 2021 (Filed With SEC on July 6, 2021)

Amendment to the Advaxis, Inc. 2015 Incentive Plan, dated as of February 11, 2021 (Filed With SEC on June 4, 2021)

Form of Accompanying Warrant (Filed With SEC on April 12, 2021)

Form of Investor Agreement (Filed With SEC on April 12, 2021)

Securities Purchase Agreement dated April 12, 2021, by and among Advaxis, Inc. and the purchasers identified on the signature pages thereto (Filed With SEC on April 12, 2021)

Form of Private Placement Warrant (Filed With SEC on April 12, 2021)

Form of Pre-Funded Warrant (Filed With SEC on April 12, 2021)

Placement Agent Agreement dated April 12, 2021, between Advaxis, Inc. and A.G.P./Alliance Global Partners (Filed With SEC on April 12, 2021)

Lease Agreement, dated March 25, 2021, by and between the Company and Princeton Corporate Plaza, LLC (Filed With SEC on March 30, 2021)

Form of Warrant Exchange Agreement, dated October 16, 2020 (Filed With SEC on January 22, 2021)

Form of Warrant (Filed With SEC on November 27, 2020)

Underwriting Agreement, dated as of November 24, 2020, by and between Advaxis, Inc. and A.G.P./Alliance Global Partners (Filed With SEC on November 27, 2020)

Rights Agreement, dated as of September 29, 2020, by and between Advaxis, Inc. and Continental Stock Transfer and Trust Company, as rights agent (Filed With SEC on September 29, 2020)

Registration Rights Agreement, dated July 30, 2020, by and between Advaxis, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on August 3, 2020)

Purchase Agreement, dated July 30, 2020, by and between Advaxis, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on August 3, 2020)

Sales Agreement, dated May 8, 2020, by and between Advaxis, Inc. and A.G.P./Alliance Global Partners (Filed With SEC on May 8, 2020)

Placement Agent Agreement dated January 21, 2020, between Advaxis, Inc. and A.G.P./Alliance Global Partners (Filed With SEC on January 23, 2020)

Securities Purchase Agreement dated January 21, 2020, by and among Advaxis, Inc. and the purchasers identified on the signature pages thereto (Filed With SEC on January 23, 2020)

Form of Warrant (Filed With SEC on January 23, 2020)

Form of Exchange Agreement dated March 14, 2019 (Filed With SEC on September 9, 2019)

Warrant Agency Agreement, entered into by Advaxis, Inc. on July 25, 2019 with Continental Stock Transfer and Trust Company (Filed With SEC on July 25, 2019)

Underwriting Agreement, entered into by Advaxis, Inc. on July 23, 2019 with A.G.P./ Alliance Global Partners (Filed With SEC on July 25, 2019)

Form of Warrant Agency Agreement, between Advaxis, Inc. and Continental Stock Transfer and Trust Company (Filed With SEC on July 22, 2019)

Form of Underwriting Agreement (Filed With SEC on July 22, 2019)

Form of Warrant Agency Agreement, between Advaxis, Inc. and Continental Stock Transfer and Trust Company (Filed With SEC on July 17, 2019)

Form of Underwriting Agreement (Filed With SEC on July 17, 2019)

Form of Exchange Agreement dated March 14, 2019 (Filed With SEC on June 10, 2019)

Underwriting Agreement, entered into by Advaxis, Inc. on April 3, 2019 with A.G.P./ Alliance Global Partners (Filed With SEC on April 5, 2019)

Advaxis, Inc. (44)